Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
暂无分享,去创建一个
Michael Ingrisch | Harun Ilhan | Andrei Todica | Matthias Fabritius | M. Ingrisch | E. D. De Toni | M. Fabritius | H. Ilhan | P. Paprottka | Franziska Schöppe | Karolin Paprottka | Frederik F Strobl | Enrico N De Toni | Marlies Michl | Philipp Marius Paprottka | A. Todica | F. Strobl | M. Michl | K. Paprottka | Franziska Schöppe
[1] P. Galle,et al. Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial , 2014, Trials.
[2] H. Rudney,et al. Studies on cholinesterase: 1. Cholinesterase and pseudo-cholinesterase. , 1943, The Biochemical journal.
[3] M. Reiser,et al. Radioembolization of Symptomatic, Unresectable Neuroendocrine Hepatic Metastases Using Yttrium-90 Microspheres , 2012, CardioVascular and Interventional Radiology.
[4] Marcus Hacker,et al. Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancer , 2013, European Radiology.
[5] A. Haug,et al. Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients , 2016, The Journal of Nuclear Medicine.
[6] Paul Kinahan,et al. Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.
[7] Martin Sill,et al. Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response , 2016, Clinical Cancer Research.
[8] M. Reiser,et al. Defining predictors for long progression-free survival after radioembolisation of hepatic metastases of neuroendocrine origin , 2013, European Radiology.
[9] W. Sommer,et al. Robust evidence for long-term survival with 90Y radioembolization in chemorefractory liver-predominant metastatic colorectal cancer , 2016, European Radiology.
[10] Hemant Ishwaran,et al. Identifying Important Risk Factors for Survival in Patient With Systolic Heart Failure Using Random Survival Forests , 2011, Circulation. Cardiovascular quality and outcomes.
[11] I. Steffen,et al. Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system , 2016, BMC Cancer.
[12] Xi Chen,et al. Random survival forests for high‐dimensional data , 2011, Stat. Anal. Data Min..
[13] M. Ingrisch,et al. Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[14] Carsten Denkert,et al. Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization , 2012, PloS one.
[15] Hemant Ishwaran,et al. Random Survival Forests , 2008, Wiley StatsRef: Statistics Reference Online.
[16] Maximilian Reiser,et al. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma , 2017, Investigative radiology.
[17] P. Malfertheiner,et al. The effectiveness of selective internal radiation therapy in challenging cases of liver-predominant unresectable hepatocellular carcinoma. , 2014, Future oncology.